Metastatic Pancreatic Ductal Adenocarcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (13 August 2021) | Viewed by 10812
Special Issue Editors
Interests: pancreatic tumor microenvironment; targeted therapies; metastasis
Special Issue Information
Dear Colleagues,
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and is almost always associated with overt or occult metastasis at the time of clinical diagnosis. This malignancy is characterized by a highly complex and heterogeneous tumor microenvironment that contributes to therapy resistance and metastasis. The articles in this Special Issue will focus on various driver genes, signaling pathways, metabolic alterations, and cellular and acellular components that contribute to the metastatic fitness of pancreatic cancer cells. The issue will also focus on various aspects or organotropism and discuss how components of the immune system contribute to metastatic spread. Finally, the articles will also discuss various experimental models being employed to study pancreatic cancer metastasis and preclinical test experimental therapeutics targeting metastatic disease and provide an update on the clinical challenges in combating metastatic PDAC.
Prof. Dr. Maneesh JainProf. Dr. Surinder K. Batra
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic ductal adenocarcinoma
- metastasis
- metastatic fitness
- tumor microenvironment
- organotropism
- metastatic niche
- metabolomics
- cancer stem cells
- immune cells
- animal models
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.